Meridian Bioscience Announces the Launch of TruQuick™ Rapid Tests for Asia Pacific
February 03, 2017 10:55 ET
|
Meridian Bioscience, Inc.
CINCINNATI, Feb. 03, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the launch of TruQuick™, a comprehensive point-of-care product menu of rapid tests for the...
Meridian Bioscience Reports First Quarter 2017 Operating Results, Reduces Regular Cash Dividend, and Revises Fiscal 2017 Guidance Downward
January 25, 2017 07:30 ET
|
Meridian Bioscience, Inc.
GENERAL HIGHLIGHTS CINCINNATI, Jan. 25, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today: reported first quarter net revenues of $46.8 million, a decrease of 1% from the same...
Bioline lanza la gama completa de ensayos EPIK™ miRNA
January 10, 2017 12:48 ET
|
Meridian Bioscience, Inc.
CINCINNATI, Jan. 10, 2017 (GLOBE NEWSWIRE) -- Bioline, The PCR Company, una filial en propiedad absoluta de Meridian Bioscience, Inc. (NASDAQ:VIVO) ha anunciado hoy la ampliación de los ensayos de...
Bioline เปิดตัวชุดตรวจ EPIK™ miRNA อย่างเต็มรูปแบบ
January 10, 2017 12:48 ET
|
Meridian Bioscience, Inc.
CINCINNATI, Jan. 11, 2017 (GLOBE NEWSWIRE) -- Bioline ซึ่งเป็นบริษัท PCR อันเป็นหนึ่งในบริษัทในเครือที่ถือหุ้นทั้งหมด ของ Meridian Bioscience, Inc. (NASDAQ:VIVO) วันนี้ได้ประกาศการขยายตัวของชุดตรวจ...
Bioline推出全方位的EPIK™ miRNA检测
January 10, 2017 12:48 ET
|
Meridian Bioscience, Inc.
辛辛那提, Jan. 11, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. （NASDAQ代号：VIVO）旗下从事聚合酶链反应(PCR)产品业务的全资附属公司Bioline今日宣布扩增最初针对单个微型核糖核酸(miRNA)分子研究开发的EPIK™...
Bioline Meluncurkan Sejumlah Penetapan Kadar miRNA EPIK™
January 10, 2017 12:48 ET
|
Meridian Bioscience, Inc.
CINCINNATI, Jan. 11, 2017 (GLOBE NEWSWIRE) -- Bioline, Perusahaan PCR, anak perusahaan yang sepenuhnya dimiliki oleh Meridian Bioscience, Inc. (NASDAQ: VIVO) hari ini mengumumkan pengembangan...
バイオライン、エピックmiRNAアッセイ各種を発表
January 10, 2017 12:48 ET
|
Meridian Bioscience, Inc.
シンシナティ, Jan. 11, 2017 (GLOBE NEWSWIRE) -- メリディアン･バイオサイエンス社 (Meridian Bioscience, Inc.、NASDAQ:VIVO) の完全所有子会社であるPCR企業、バイオライン (Bioline) は本日、当初は個別のマイクロRNA (miRNA) の研究のために開発されたエピックmiRNAセレクト･アッセイ (EPIK™...
Bioline lança conjunto completo de ensaios de miRNA EPIK™
January 10, 2017 12:48 ET
|
Meridian Bioscience, Inc.
CINCINNATI, Jan. 10, 2017 (GLOBE NEWSWIRE) -- A Bioline, empresa de RCP, subsidiária integral da Meridian Bioscience, Inc. (NASDAQ:VIVO), anunciou hoje a expansão dos ensaios de miRNA EPIK™...
Bioline推出全方位的EPIK™ miRNA檢測
January 10, 2017 12:48 ET
|
Meridian Bioscience, Inc.
辛辛那提, Jan. 11, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. （NASDAQ代號：VIVO）旗下從事聚合酶鏈反應(PCR)產品業務的全資附屬公司Bioline今日宣佈擴增最初針對單個微型核糖核酸(miRNA)分子研究開發的EPIK™...
Bioline Lancarkan Rangkaian Penuh Cerakin EPIK™ miRNA
January 10, 2017 12:48 ET
|
Meridian Bioscience, Inc.
CINCINNATI, Jan. 11, 2017 (GLOBE NEWSWIRE) -- Bioline, Syarikat PCR, anak syarikat milik penuh Meridian Bioscience Inc. (NASDAQ:VIVO) hari ini mengumumkan pengembangan Cerakin PIlih EPIK™ miRNA yang...